DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Clinical Microbiology Market Revenue Analysis By Product, By Application And Segment Forecasts To 2024" report to their offering.
The global clinical microbiology market was valued at USD 8.4 billion in 2015 and is expected to reach a value of USD 16.1 billion by 2024. Key factors driving the market growth include constant introduction of advanced products coupled with increasing demand in pharmaceuticals, and clinical applications for investigation and diagnosis of various infectious diseases.
The market is rapidly growing due to the increasing adoption of automated and advanced technologies for laboratory instruments and analyzers in developed countries. A growing geriatric population and thereby a rising prevalence of infectious diseases is one of the major factors boosting the adoption of clinical microbiology in healthcare sector for disease diagnosis and monitoring. In addition, industry is gaining high momentum with launch of innovative products such as MALDI Biotyper, GeneXpert and Myla IT performance management solutions. Moreover, with the U.S. FDA approving the Xpert Carba-R, commercialization of clinical microbiology devices is expected to increase significantly over the next few years.
The clinical microbiology Industry is presently dominated by a few key participants such as bioMerieux S.A., Cepheid Inc., Danaher Corporation and Bruker Corporation. Some of the prominent players operating in the market include but are not limited to Becton Dickinson & Company, Hologic Inc., Roche Diagnostics and Alere Inc.
Report Structure:
1 Research Methodology
2 Executive Summary
3 Market Snapshot
4 Market Variables, Trends & Scope
5 Market Categorization 1: Product Estimates & Trend Analysis
6 Market Categorization 2: Application Estimates & Trend Analysis
7 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application type
8 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/z4n6bk/clinical
